Burke William Patrick's Form 4 filing
NovoCure Ltd (NVCR) · filed Jan 5, 2022
- Accession no.
- 0001645113-22-000001
- Filed
- Jan 5, 2022
- Trade date
- Jan 3, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $300.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burke William PatrickCIK 0001880493 | Officer (Chief Human Resources Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Ordinary Shares | MOption exerciseAcquired | +17,452 | $11.46 | +$199,999.92 | 43,669 | Direct | |
| Jan 3, 2022 | Ordinary Shares | SSaleDisposed | −2,633 | $75.96 | −$200,002.68 | 41,036 | Direct | |
| Jan 3, 2022 | Ordinary Shares | MOption exerciseAcquired | +9,750 | $7.15 | +$69,712.5 | 50,786 | Direct | |
| Jan 3, 2022 | Ordinary Shares | SSaleDisposed | −919 | $76.09F2 | −$69,926.71 | 49,867 | Direct | |
| Jan 3, 2022 | Ordinary Shares | MOption exerciseAcquired | +1,402 | $21.60 | +$30,283.2 | 51,269 | Direct | |
| Jan 3, 2022 | Ordinary Shares | SSaleDisposed | −399 | $76.03 | −$30,335.97 | 50,870 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Ordinary Shares | MOption exerciseDisposed | −17,452 | $0.00 | $0 | 0 | Direct | |
| Jan 3, 2022 | Ordinary Shares | MOption exerciseDisposed | −9,750 | $0.00 | $0 | 0 | Direct | |
| Jan 3, 2022 | Ordinary Shares | MOption exerciseDisposed | −1,402 | $0.00 | $0 | 6,098 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
On January 3, 2022, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke, Mr. Burke sold 919 shares in multiple trades at prices ranging from $76.00 to $76.09. The price reported above reflects the weighted average sale price. Mr. Burke hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.